SORD
protein-codingsorbitol dehydrogenase
Gene summary
Sorbitol dehydrogenase (SORD; EC 1.1.1.14) catalyzes the interconversion of polyols and their corresponding ketoses, and together with aldose reductase (ALDR1; MIM 103880), makes up the sorbitol pathway that is believed to play an important role in the development of diabetic complications (summarized by Carr and Markham, 1995 [PubMed 8535074]). The first reaction of the pathway (also called the polyol pathway) is the reduction of glucose to sorbitol by ALDR1 with NADPH as the cofactor. SORD then oxidizes the sorbitol to fructose using NAD(+) cofactor.[supplied by OMIM, Jul 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~54.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0030055
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0015626
Submitter: ClinGen
SORD was first reported in relation to autosomal recessive Charcot-Marie-Tooth disease (CMT) in 2020 (Cortese et al., PMID: 32367058). SORD neuropathy (OMIM: 618912) is caused by loss of the enzyme sorbitol dehydrogenase, which converts sorbitol to fructose, leading to toxic accumulation of sorbitol levels. Patients with SORD variants develop CMT2 or distal hereditary motor neuropathy (dHMN). SORD deficiency is one of the most common types of recessive CMT, with an estimated prevalence of 1 to 100,000 individuals. In this curation, we have included 5 probands from three different publications, all harboring a common frameshift variant (Ala253GlnfsTer27), presented as homozygous or compound heterozygous (PMID: 32367058, 34995833, and 33875678). The most common pathogenic variant is present at a relatively high allele frequency in the population (gnomAD= 0.0004). More evidence is available in the literature, but the maximum score for the genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be loss-of-function. This gene-disease association is also supported by experimental evidence (expression studies, animal model, and functional alteration in patient cells)(PMID: 32367058 and 9604875). Fibroblasts and serum from patients show abnormally increased levels of sorbitol. Loss of the SORD gene ortholog in Drosophila caused synaptic degeneration, progressive motor impairment, and increased sorbitol levels, which were rescued by treatment with aldose reductase inhibitors (PMID: 32367058). A total of 15.5 points have been obtained for this curation. In summary, SORD is definitively associated with autosomal recessive CMT. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0030055
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0030055
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Biochemical; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SORD variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003104.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 17 | 6 | 24 | ||
| missense | 1 | 5 | 66 | 5 | 2 | 79 |
| nonsense | 2 | 2 | 4 | |||
| start loss | 0 | |||||
| frameshift | 1 | 2 | 2 | 5 | ||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 3 | |||
| Total | 4 | 10 | 71 | 22 | 8 | 115 |
Highest pathogenic variant AF is 0.0031969629
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003095.2 | 9 | MANE Select | |
| Ensembl | ENSP00000267814.9 | 9 | MANE Select | |
| Ensembl | ENSP00000453904.1 | 4 | Standard | |
| Ensembl | ENSP00000452731.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Fructose and mannose metabolism - Homo sapiens (human)
- Pentose and glucuronate interconversions - Homo sapiens (human)
- Fructose intolerance, hereditary
- Fructose and Mannose Degradation
- Fructosuria
Biological Process
- glucose metabolic process
- sorbitol catabolic process
- response to osmotic stress
- response to hormone
- glucuronate catabolic process to xylulose 5-phosphate
Molecular Function
- L-iditol 2-dehydrogenase activity
- zinc ion binding
- carbohydrate binding
- identical protein binding
- D-xylulose reductase activity
Cellular Component
- extracellular space
- cytosol
- membrane
- motile cilium
- mitochondrial membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000267814
- Coding exons
- 9
- Length
- 54082
- Individuals with no LoFs
- 125678
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 70
- Defined
- 125748
- p
- 0.000278
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.351 | 185 | 172 | 1.08 | 0.00000953 | 2254 |
| Missense (PolyPhen) | 62 | 62.735 | 0.98829 | 746 | ||
| Synonymous | -0.588 | 75 | 68.8 | 1.09 | 0.00000406 | 729 |
| Loss of Function | 0.739 | 13 | 16.2 | 0.802 | 0.00000104 | 204 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00032 | 0.00031 | rare |
| Latino/Admixed American | 0.00081 | 0.00078 | rare |
| Ashkenazi Jewish | 0.00024 | 0.00020 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00023 | 0.00023 | rare |
| South Asian | 0.00027 | 0.00026 | rare |
| Other | 0.00034 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Converts sorbitol to fructose. Part of the polyol pathway that plays an important role in sperm physiology. May play a role in the sperm motility by providing an energetic source for sperm. {ECO:0000250|UniProtKB:Q64442, ECO:0000269|PubMed:16278369}.;
Recessive Scores
- pRec
- 0.603
Intolerance Scores
- LoFtool
- 0.766
- RVIS EVS
- 0.86
- RVIS percentile EVS
- 88.74
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.607
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |